Nitrous oxide-antinociception is mediated by opioid receptors and nitric oxide in the periaqueductal gray region of the midbrain

European Neuropsychopharmacology

Volumn 18, Issue 3, 2008, Pages 194-199

  Emmanouil, Dimitris E ^a   Dickens, Andrea S ^b   Heckert, Rick W ^b   Ohgami, Yusuke ^b   Chung, Eunhee ^b   Han, Shujie ^b   Quock, Raymond M ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Antinociception; Nitric oxide; Nitrous oxide; Opioid receptors; Periaqueductal gray

Indexed keywords

1 (2 TRIFLUOROMETHYLPHENYL)IMIDAZOLE; CHLORNALTREXAMINE; N(G) METHYLARGININE; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROUS OXIDE; OPIATE ANTAGONIST; OPIATE RECEPTOR; OXYGEN;

ABDOMINAL BLUNT TRAUMA; ABDOMINAL CONSTRICTION TEST; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HISTOPATHOLOGY; MALE; MESENCEPHALON; MICROINJECTION; MOUSE; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; PROTEIN LOCALIZATION; STEREOTAXIC SURGERY;

ANALGESICS, NON-NARCOTIC; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MESENCEPHALON; MICE; MICROINJECTIONS; NALTREXONE; NITRIC OXIDE; NITROUS OXIDE; PAIN MEASUREMENT; PERIAQUEDUCTAL GRAY; RECEPTORS, OPIOID;

EID: 38149083364     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2007.06.008     Document Type: Article

References (31)

1. Abacioglu N., Ozmen R., Cakici I., Tunctan B., and Kanzik I. Role of l-arginine/nitric oxide pathway in the antinociceptive activities of morphine and mepyramine in mice. Arzneimittelforschung 51 (2001) 977-983
2. Berkowitz B.A., Ngai S.H., and Finck A.D. Nitrous oxide "analgesia": resemblance to opiate action. Science 194 (1976) 967-968
3. Branda E.M., Ramza J.T., Cahill F.J., Tseng L.F., and Quock R.M. Role of brain dynorphin in nitrous oxide antinociception in mice. Pharmacol. Biochem. Behav. 65 (2000) 217-222
4. Cahill F.J., Ellenberger E.A., Mueller J.L., Tseng L.F., and Quock R.M. Antagonism of nitrous oxide antinociception in mice by intrathecally administered opioid peptide antisera. J. Biomed. Sci. 7 (2000) 299-303
5. Dewey W.L., Harris L.S., Howes J.F., and Nuite J. The effect of various neurohumoral modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone tests. J. Pharmacol. Exp. Ther. 175 (1970) 435-442
6. Duarte I.D., and Ferreira S.H. The molecular mechanism of central analgesia induced by morphine or carbachol and the l-arginine-nitric oxide-cGMP pathway. Eur. J. Pharmacol. 221 (1992) 171-174
7. Fang F., Guo T.Z., Davies M.F., and Maze M. Opiate receptors in the periaqueductal gray mediate analgesic effect of nitrous oxide in rats. Eur. J. Pharmacol. 336 (1997) 137-141
8. Franklin K.B.J., and Paxinos G. The mouse brain in stereotaxic coordinates. 2nd ed (2001), Academic Press, San Diego
9. Fujinaga M., and Maze M. Neurobiology of nitrous oxide-induced antinociceptive effects. Mol. Neurobiol. 25 (2002) 167-189
10. Hara S., Kuhns E.R., Ellenberger E.A., Mueller J.L., Shibuya T., Endo T., and Quock R.M. Involvement of nitric oxide in intracerebroventricular β-endorphin-induced neuronal release of methionine-enkephalin. Brain Res. 675 (1995) 190-194
11. Heinzen E.L., and Pollack G.M. The development of morphine antinociceptive tolerance in nitric oxide synthase-deficient mice. Biochem. Pharmacol. 67 (2004) 735-741
12. Heinzen E.L., Booth R.G., and Pollack G.M. Neuronal nitric oxide modulates morphine antinociceptive tolerance by enhancing constitutive activity of the mu-opioid receptor. Biochem. Pharmacol. 69 (2005) 679-688
13. Henry E.D., Ohgami Y., Li S., Chung E., and Quock R.M. Correlation of inbred mouse sensitivity to nitrous oxide antinociception with brain NOS activity following exposure to nitrous oxide. Pharmacol. Biochem. Behav. 81 (2005) 764-768
14. Hodges B.L., Gagnon M.J., Gillespie T.R., Breneisen J.R., O'Leary D.F., Hara S., and Quock R.M. Antagonism of nitrous oxide antinociception in the rat hot plate test by site-specific μ- and ε-opioid receptor blockade. J. Pharmacol. Exp. Ther. 269 (1994) 596-600
15. Ishikawa M., and Quock R.M. Role of nitric oxide synthase isoforms in nitrous oxide antinociception in mice. J. Pharmacol. Exp. Ther. 306 (2003) 484-489
16. 2O stimulates NOS enzyme activity in C57BL/6 but not DBA/2 mice. Brain Res. 976 (2003) 262-263
17. Jacquet Y.F., and Lajtha A. Paradoxical effects after microinjection of morphine in the periaqueductal gray matter in the rat. Science 185 (1974) 1055-1057
18. Kolesnikov Y.A., Pick C.G., Ciszewska G., and Pasternak G.W. Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitor. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 5162-5166
19. Li S., Ohgami Y., Dai Y., and Quock R.M. Antagonism of nitrous oxide-induced behavior in mice by pharmacologic disruption of endogenous nitric oxide function. Psychopharmacology 166 (2003) 366-372
20. Li S., Bieber A.J., and Quock R.M. Antagonism of nitrous oxide antinociception in mice by antisense oligodeoxynucleotide directed against neuronal nitric oxide synthase enzyme. Behav. Brain Res. 152 (2004) 361-363
21. Litchfield J.T., and Wilcoxon F. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96 (1949) 99-108
22. Majeed N.H., Przewlocka B., Machelska H., and Przewlocki R. Inhibition of nitric oxide synthase attenuates the development of morphine tolerance and dependence in mice. Neuropharmacology 33 (1994) 189-192
23. McDonald C.E., Gagnon M.J., Ellenberger E.A., Hodges B.L., Ream J.K., Tousman S.A., and Quock R.M. Inhibitors of nitric oxide synthesis antagonize nitrous oxide antinociception in mice and rats. J. Pharmacol. Exp. Ther. 269 (1994) 601-608
24. Ohgami Y., Chung E., and Quock R.M. Exposure to nitrous oxide causes a nitric oxide-dependent release of β-endorphin in the rat arcuate nucleus. Abstracts of Banff 2007, West. Pharmacol. Soc. Ann. Mtg., Banff, Alberta, Canada (2007) 45
25. Ozek M., Uresin Y., and Gungor M. Comparison of the effects of specific and nonspecific inhibition of nitric oxide synthase on morphine analgesia, tolerance and dependence in mice. Life Sci. 72 (2003) 1943-1951
26. Pataki I., and Telegdy G. Further evidence that nitric oxide modifies acute and chronic morphine actions in mice. Eur. J. Pharmacol. 357 (1998) 157-162
27. Pelligrino D.A., Laurito C.E., and VadeBoncouer T.R. Nitric oxide synthase inhibition modulates the ventilatory depressant and antinociceptive actions of fourth ventricular infusions of morphine in the awake dog. Anesthesiology 85 (1996) 1367-1377
28. Quock R.M., and Graczak L.M. Influence of narcotic antagonist drugs upon nitrous oxide analgesia in mice. Brain Res. 440 (1988) 35-41
29. Sharpe L.G., Garnett J.E., and Cicero T.J. Analgesia and hyperreactivity produced by intracranial microinjections of morphine into the periaqueductal gray matter of the rat. Behav. Biol. 11 (1974) 303-313
30. Xu J.Y., and Tseng L.F. Increase of nitric oxide by l-arginine potentiates β-endorphin- but not μ-, δ or κ-opioid agonist-induced antinociception in the mouse. Eur. J. Pharmacol. 236 (1993) 137-142
31. Zuniga J., Joseph S., and Knigge K. Nitrous oxide analgesia: partial antagonism by naloxone and total reversal after periaqueductal gray lesions in the rat. Eur. J. Pharmacol. 142 (1987) 51-60